M. Kamil M, Jabarah MA-H, A.l. Jasim N. Immunogenicity of the biosimilar CT-P13 infliximab or the original infliximab in Iraqi patients with Ankylosing spondylitis does not correlate with their demographic characteristics. JFacMedBagdad [Internet]. 2023 Jan. 13 [cited 2024 May 5];64(4):261-7. Available from: https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1969